🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide MASH Phase 2b — March 2026 Page 6

Survodutide MASH Phase 2b — March 2026

CanadaChris Tue, May 20, 2025 at 9:27 PM 31 replies 1,956 viewsPage 6 of 7
pete_RVA
Member
178
890
Dec 2024
Richmond, VA
May 21, 2025 at 5:57 AM#26

Congrats CanadaChris!! You should be so proud of yourself. 🎉

13 20mike_mod, SarahChen_PharmD, sarah.morrison and 10 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
May 21, 2025 at 6:14 AM#27

Slightly tangential to Survodutide MASH Phase 2b but Admin reminded me — does anyone have experience combining this with metformin?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: May 21, 2025 at 10:14 AM
20 6dave_SLC, FDA_TrackerJim, ricardo_MIA and 17 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
May 21, 2025 at 6:31 AM#28

Yep. My endo said the same thing about Survodutide MASH.

1 1Dr.EndoIndy
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
RickReta_CO
Member
312
1,234
Jan 2025
Colorado
May 21, 2025 at 6:48 AM#29

Reading this thread on Survodutide MASH Phase 2b hits close to home. Night shift nurse — I started at 267 lbs and felt like I would tried everything.

13 months on tirz and I am a different person. Not just the 42 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Survodutide MASH — take the leap. It was the best health decision I have ever made. ❤️

Last edited: May 21, 2025 at 11:48 AM
31 6tommy_boulder, hyun_seoul, jim_asheville and 28 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
May 21, 2025 at 7:05 AM#30

As a pharmacist, I want to add some clinical context to this discussion on Survodutide MASH Phase 2b March 2026.

Building on what TirzTom said — the evidence base here is robust. The key publications to reference are from the SELECT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
4 16LipidDoc_ATL, BariatricNurseD, MASHdoc_SA and 1 other
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register